Key Points
- Insider sale: Billiontoone insider Shan Riku Sakakibara sold 8,000 shares on July 9 at an average price of $125, totaling $1 million. After the transaction, he still owned 204,000 shares, and the sale was made under a pre-arranged Rule 10b5-1 plan.
- Recent selling trend: This follows two earlier sales by Sakakibara in June, each for 8,000 shares, indicating a series of planned stock dispositions over the past month.
- Company performance and outlook: Billiontoone recently beat earnings and revenue expectations, reporting $0.34 EPS on $108.39 million in revenue, while analysts maintain an average Moderate Buy rating with a consensus price target of $126.
Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report) insider Shan Riku Sakakibara sold 8,000 shares of the business's stock in a transaction that occurred on Thursday, July 9th. The stock was sold at an average price of $125.00, for a total transaction of $1,000,000.00. Following the completion of the sale, the insider owned 204,000 shares of the company's stock, valued at approximately $25,500,000. The trade was a 3.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Shan Riku Sakakibara also recently made the following trade(s):
- On Wednesday, June 24th, Shan Riku Sakakibara sold 8,000 shares of Billiontoone stock. The shares were sold at an average price of $110.00, for a total transaction of $880,000.00.
- On Monday, June 8th, Shan Riku Sakakibara sold 8,000 shares of Billiontoone stock. The shares were sold at an average price of $98.22, for a total transaction of $785,760.00.
Billiontoone Price Performance
Shares of NASDAQ:BLLN opened at $123.25 on Tuesday. The company has a quick ratio of 10.58, a current ratio of 10.92 and a debt-to-equity ratio of 0.18. The stock has a market cap of $5.67 billion and a PE ratio of 224.09. The company's fifty day moving average is $101.46 and its 200 day moving average is $89.09. Billiontoone, Inc. has a 52 week low of $61.96 and a 52 week high of $138.70.
Billiontoone (NASDAQ:BLLN - Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.01 by $0.33. The company had revenue of $108.39 million for the quarter, compared to the consensus estimate of $95.81 million. The firm's quarterly revenue was up 83.8% compared to the same quarter last year. During the same period last year, the business posted ($0.39) earnings per share. Research analysts anticipate that Billiontoone, Inc. will post 0.93 earnings per share for the current year.
Institutional Trading of Billiontoone
Large investors have recently modified their holdings of the business. Rossby Financial LCC purchased a new position in Billiontoone during the 4th quarter valued at about $25,000. Wells Fargo & Company MN purchased a new stake in Billiontoone in the 4th quarter worth approximately $76,000. Smartleaf Asset Management LLC purchased a new stake in Billiontoone in the 4th quarter worth approximately $80,000. Nano Cap New Millennium Growth Fund L P bought a new stake in shares of Billiontoone in the 4th quarter worth approximately $82,000. Finally, Thrive Wealth Management LLC purchased a new position in shares of Billiontoone during the second quarter valued at approximately $240,000.
Wall Street Analysts Forecast Growth
BLLN has been the topic of several recent research reports. BTIG Research reduced their price target on Billiontoone from $140.00 to $130.00 and set a "buy" rating on the stock in a research report on Thursday, May 7th. JPMorgan Chase & Co. increased their price objective on Billiontoone from $120.00 to $125.00 and gave the company an "overweight" rating in a research note on Thursday, May 7th. Guggenheim assumed coverage on shares of Billiontoone in a report on Monday, June 29th. They issued a "buy" rating and a $125.00 target price on the stock. Finally, Weiss Ratings raised shares of Billiontoone from a "sell (d)" rating to a "sell (d+)" rating in a research note on Tuesday, June 23rd. Six investment analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, Billiontoone has an average rating of "Moderate Buy" and a consensus price target of $126.00.
Read Our Latest Analysis on BLLN
Billiontoone Company Profile
(
Get Free Report)
BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.
BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.
See Also
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
